Company intelligence / Profile preview

CHADIS

Baltimore, Maryland, United Statessite.chadis.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company’s main product, the CHADIS platform, has been widely adopted by clinicians for online screening, patient engagement, and clinical process support. It has received over $15 million in federal and foundation grants for research and development. Thirteen NIH/CDC SBIR awards have supported its innovation. The system supports early detection of mental, behavioral, developmental issues as well as routine check-ups.

Therapeutic areas: OtherPsychiatryNeurology
Modalities: Non-pharmacological therapy (digital health platform)
Industry: Digital Health Medical Devices

Partnerships

Center for Promotion of Child Development through Primary Care (non-profit research partner)

Beyond the preview

Go deeper on CHADIS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CHADIS.

Explore the full profile